Skip to main content

Table 3 LA/Ao-Ratio and LVIDDN of all dogs at the different examination times

From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

Day 0

Day 90

Day 180

 

LA/Ao

LVIDDN

LA/Ao

LVIDDN

LA/Ao

LVIDDN

Group

1.22

1.42

1.22

1.57

1.35

1.36

A

1.00

1.73

1.37

1.55

1.39

1.45

A

1.22

1.46

1.33

1.33

1.33

1.37

A

1.15

1.43

1.15

1.26

1.15

1.26

A

0.95

1.41

1.30

0.97

1.18

1.04

A

1.43

1.61

1.22

1.52

1.20

1.42

A

1.11

1.78

1.27

1.81

1.06

2.00

A

1.27

1.60

1.23

1.41

1.53

1.58

A

1.46

1.51

1.32

1.52

1.34

1.59

A

1.35

1.70

1.46

1.63

1.31

1.75

A

1.07

1.65

1.50

1.65

1.51

1.70

B

1.24

1.62

1.11

1.40

1.09

1.63

B

1.30

1.55

1.30

1.67

1.22

1.42

B

1.51

1.76

1.40

1.55

1.70

1.60

B

1.17

1.67

1.47

1.73

1.30

1.72

B

1,28

1.58

1.34

1.40

1.49

1.50

B

1,22

1.56

1.06

1.66

1.40

1.38

B

1,29

1.86

1.13

1.60

1.38

1.79

B

1,30

1.63

1.41

1.42

1.38

1.67

B

1,42

1.34

1.42

1.28

1.25

1.26

B